Researchers at The Hospital for Sick Children (SickKids), working with international collaborators and youth and family ...

In a 12-week randomized phase IIa trial in adults with obesity, the dual GLP-1/GLP-2 receptor agonist dapiglutide was well ...

The Trump administration has pledged to conduct its own studies, but research continues to contradict its claims.

Doctors say that identifying the right patients will be critical to the future of the field. Only time will tell, according to trialists.

Taking ashwagandha for up to three months may improve sleep quality and reduce anxiety and stress. However, its long-term safety beyond this period is not well known.

In 2024, the FDA granted 510(k) clearance to a hemodialysis machine capable of delivering online high-volume hemodiafiltration. Since then, companies have started phased introduction of the system ...

Conservation has never lacked ideas. Protected areas, payments for ecosystem services, community management, certification schemes, and public campaigns have all been promoted as solutions to ...

BACKGROUND: Inconsistent selection of reference groups may contribute to inconclusive blood pressure control targets for patients with hypertension. This study aims to identify optimal systolic blood ...

Early clinical trials established the safety and feasibility of closed-loop insulin delivery, but the 2019 iDCL trial1 marked the first large, outpatient, randomised, controlled trial to show a ...

Researchers are evaluating the P-CARE model, which integrates results from a blended genome-exome sequencing assay and family ...

DMT therapy significantly reduced major depressive disorder symptoms in a phase IIa trial. Learn more about this rapid-acting ...

Anthropic research shows developers using AI assistance scored 17% lower on comprehension tests when learning new coding ...